Tagged pinneyassociates

Developing Psychedelics Into Medicine: Potential and Pitfalls, New Webinar Hosted by Xtalks
Press Release

Developing Psychedelics Into Medicine: Potential and Pitfalls, New Webinar Hosted by Xtalks

 Read More
Crossing the Blood-Brain Barrier - the Human Element of Abuse Potential Assessment, New Webinar Hosted by Xtalks
Press Release

Crossing the Blood-Brain Barrier - the Human Element of Abuse Potential Assessment, New Webinar Hosted by Xtalks

 CNS drug developers have to focus on physical safety and efficacy first, especially when developing products for rare disorders or diagnoses that are often unresponsive to other therapies. Although these products rarely have notable CNS mediated side effects, they fall under the FDA's requirement for an abuse potential assessment because they cross the blood-brain barrier. Read More
Upcoming Xtalks Webinar: Crossing the Blood-Brain Barrier? FDA Requires an Abuse Potential Assessment
Press Release

Upcoming Xtalks Webinar: Crossing the Blood-Brain Barrier? FDA Requires an Abuse Potential Assessment

 Read More
Cannabinoid Abuse Potential Assessment: The 8-Factor Analysis as an Opportunity, New Webinar Hosted by Xtalks
Press Release

Cannabinoid Abuse Potential Assessment: The 8-Factor Analysis as an Opportunity, New Webinar Hosted by Xtalks

 Presenters will focus on the role of an abuse potential assessment (also referred to as the Controlled Substances Act 8-factor analysis) in the development of cannabinoid products and how it relates to the U.S. scheduling process, and related interactions with the FDA and DEA Read More
Rx to OTC Switch: Planning for Regulatory Success, New Webinar Hosted by Xtalks
Press Release

Rx to OTC Switch: Planning for Regulatory Success, New Webinar Hosted by Xtalks

 Read More